Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Korean Medical Science ; : 768-772, 2006.
Article Dans Anglais | WPRIM | ID: wpr-211991

Résumé

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome associated with anticonvulsant drugs is a rare but potentially life-threatening disease that occurs in response to arene oxide producing anticonvulsant such as phenytoin and carbamazepine. There have been many reports of cross reactivity among the anticonvulsants upon first exposure to the offending drugs. However, there has been few data describing the development of DRESS syndrome after switching medication from previously well-tolerated phenytoin to carbamazepine, and the induction of hypersensitivity to phenytoin by DRESS to carbamazepine. We experienced a case of a 40-yr-old man who had uncontrolled seizure that led to the change of medication from the long-term used phenytoin to carbamazepine. He developed DRESS syndrome after changing the drugs. We stopped carbamazepine and restored phenytoin for seizure control, but his clinical manifestations progressively worsened and he recovered only when both drugs were discontinued. Patch tests with several anticonvulsants showed positive reactions to both carbamazepine and phenytoin. Our case suggests that hypersensitivity to a previously tolerated anticonvulsant can be induced by DRESS to another anticonvulsant, and that the patch test may be a useful method for detecting cross-reactive drugs in anticonvulsant-associated DRESS syndrome.


Sujets)
Mâle , Humains , Adulte , Syndrome , Peau/effets des médicaments et des substances chimiques , Phénytoïne/immunologie , Hypersensibilité médicamenteuse/immunologie , Toxidermies/étiologie , Carbamazépine/effets indésirables , Anticonvulsivants/effets indésirables
2.
Arch. argent. dermatol ; 44(2): 61-5, mar.-abr. 1994. ilus
Article Dans Espagnol | LILACS | ID: lil-136630

Résumé

Dos semanas después de iniciar una terapéutica con difenilhidantoína, un paciente presenta un cuadro compatible con el Síndrome de Hipersensibilidad a los Anticonvulsivantes. Por el carácter potencialmente mortal de la entidad, se describen sus características, con el propósito de facilitar su diagnóstico precoz, poniendo especial énfasis en la adecuada selección de un anticonvulsivante sustituto, dado que pueden existir reacciones cruzadas en un alto porcentaje de los casos


Sujets)
Humains , Mâle , Adulte d'âge moyen , Anticonvulsivants/effets indésirables , Hypersensibilité médicamenteuse/étiologie , Phénytoïne/effets indésirables , Syndrome de Stevens-Johnson/étiologie , Hypersensibilité médicamenteuse/diagnostic , Hypersensibilité médicamenteuse/physiopathologie , Phénytoïne/administration et posologie , Phénytoïne/immunologie , Syndrome de Stevens-Johnson/immunologie , Syndrome de Stevens-Johnson/traitement médicamenteux
SÉLECTION CITATIONS
Détails de la recherche